CPhI Prepares for India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Prepares for India


CPhI ands its collocated events take place in various other locations outside of Europe. Following the event’s departure from Madrid, it will only be a few weeks before pharmaceutical professionals are once again networking under the CPhI name; this time in Mumbai for CPhI India.

CPhI India will take place on 21–23 November at the Bombay Exhibition Centre and will also celebrate its sixth anniversary. According to the organisers, the Indian pharmaceutical market is growing at an annual rate of 13%, twice that of the global market growth rate.

Last year’s event featured 825 exhibitors from 21 countries and regions and more than 27000 attendees from 96 countries and regions. Visitor levels are not far behind CPhI Worldwide, which has been running for considerably longer than its Indian sister event.

CPhI India will also feature some of the same collocated events that are seen at the European show: P-MEC for pharmaceutical machinery, equipment and technology; ICSE for pharmaceutical contract services and outsourcing solutions; and BioPh for bio-solutions for pharma.

You can find out more about CPhI India here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here